Circadian screening of neutrophils identifies therapeutic targets in multiple sclerosis
Proceedings of the National Academy of Sciences · 14.07.2026 · 123 (28)
DOI: 10.1073/pnas.2536812123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 08.07.2026. Verfasst von Francesco De Virgiliis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva 1211, Switzerland. Hauptthemen laut MEDLINE: Neutrophils, Encephalomyelitis, Autoimmune, Experimental, Multiple Sclerosis, Circadian Rhythm. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EC | European Research Council (ERC), Swiss National Science Foundation.
Abstract (Originalsprache)
Circadian rhythms are intrinsic time-keeping mechanisms that play a critical role in tuning immunity. Here, we investigated the impact of circadian rhythms on the pathogenesis of experimental autoimmune encephalomyelitis (EAE), a mouse model for multiple sclerosis (MS). We demonstrate that circulating neutrophils in blood significantly increase early in EAE, prior to symptoms onset. Importantly, we found that these cells infiltrate the central nervous system (CNS) in a time-of-day (ToD)-dependent manner, with increased infiltration at the onset of the behavioral active phase of the mice (evening). Transcriptomic analysis of CNS-infiltrating neutrophils revealed distinct ToD-dependent gene expression profiles, which identified Formyl peptide receptor 2 (FPR2) as a potential therapeutic candidate, since pharmacological inhibition of FPR2 led to reduced EAE disease severity. Furthermore, combinatorial treatment with a drug that targets VLA-4 (used in clinical practice under the trade name Natalizumab to treat MS) led to additive effects, substantially reducing EAE symptoms. Together, these findings highlight the importance of circadian immune cell dynamics during EAE development and provide a characterization of the circadian immune landscape in an animal model of MS, identifying potential targets for MS therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva 1211, Switzerland.
- Geneva Centre for Inflammation Research, Faculty of Medicine, University of Geneva, Geneva 1211, Switzerland.
- Translational Research Centre in Onco-Hematology, Geneva 1211, Switzerland.
- Institute of Genetics and Genomics of Geneva, University of Geneva, Geneva 1211, Switzerland.
- Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig-Maximilians-Universität München, Planegg-Martinsried 82152, Germany.
ORCID-Profile: Robert Pick, Valeria Maria Oliva, Doron Merkler, Christoph Scheiermann
Förderung
- EC | European Research Council (ERC)
- Swiss National Science Foundation
Zitieren
APA
De Virgiliis, F., Barnoud, C., He, W., Zeng, Q., Pick, R., Sun, T., Jemelin, S., Oliva, V. M., Furlan, T., Picon-Muñoz, C., Merkler, D., & Scheiermann, C. (2026). Circadian screening of neutrophils identifies therapeutic targets in multiple sclerosis. Proceedings of the National Academy of Sciences, 123(28). https://doi.org/10.1073/pnas.2536812123
Vancouver
De Virgiliis F, Barnoud C, He W, Zeng Q, Pick R, Sun T, et al. Circadian screening of neutrophils identifies therapeutic targets in multiple sclerosis. Proceedings of the National Academy of Sciences. 2026;123(28). doi:10.1073/pnas.2536812123
BibTeX
@article{DeVirgiliis2026,
author = {De Virgiliis, Francesco and Barnoud, Coline and He, Wenyan and Zeng, Qun and Pick, Robert and Sun, Tianyue and Jemelin, Stéphane and Oliva, Valeria Maria and Furlan, Tiphaine and Picon-Muñoz, Carmen and Merkler, Doron and Scheiermann, Christoph},
title = {Circadian screening of neutrophils identifies therapeutic targets in multiple sclerosis},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {28},
doi = {10.1073/pnas.2536812123}
}
EUVIMED